In light of the recent Food and Drug Administration (FDA) approval and Centers for Disease Control and Prevention (CDC) recommendation regarding the COVID-19 booster, we want to remind providers of their obligations pursuant to RIGL 27-18-86(b), which prohibits in-network providers and pharmacies from imposing member cost-sharing for the administration of the COVID-19 vaccine.

Please update your systems promptly to ensure that cost-sharing is waived for all fully insured commercial BCBSRI members who receive the COVID-19 vaccine.